Skip to main content
TipRanks
Go Ultimate75% OFF

Deepak Nitrite Limited (DEEPAKNTR) AI Stock Analysis

5 Followers
IN:DEEPAKNTR

Deepak Nitrite Limited

(NSE:DEEPAKNTR)

Select Model
Rating:52Neutral
Price Target:INR 1,606.00â–²(4.96% Upside)
Action:reiterated
Date:11/18/26

The overall score is constrained by significant financial performance weaknesses, including sharp margin erosion and negative free cash flow. Technicals show some near-term strength, but overbought stochastic signals caution. Valuation is neutral and does not compensate for fundamental risks.

Positive Factors
Diversified End MarketsExposure across agrochemicals, pharmaceuticals, dyes, plastics and other industrial markets gives Deepak Nitrite a broad demand base. This diversification can reduce reliance on any single end-use cycle and supports resilience as the company develops specialty and value-added products for domestic and export customers.
Negative Factors
Margin CompressionThe sharp decline in gross and net margins shows that earnings quality has weakened materially from prior periods. Lower profitability reduces operating leverage, limits internally funded investment, and leaves future earnings more sensitive to cost pressures or less favorable product and business mix.

Deepak Nitrite Limited (DEEPAKNTR) vs. iShares MSCI India ETF (INDA)

-20%-10%0%10%20%IN:DEEPAKNTR-2.77%INDA-2.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 208.85B
Dividend Yield
0.49%
Average Volume (3M)
41.72K
Price to Earnings (P/E)
19.7
Beta (1Y)
0.81
Revenue Growth
25.13%
EPS Growth
99.89%
Country
India
Employees
1,720
Sector
General
Sector Strength
55
Industry
Chemicals

Deepak Nitrite Limited Business Overview & Revenue Model

Company Description

Incorporated in 1970 and headquartered in Vadodara, India, Deepak Nitrite Limited operates as a prominent manufacturer and seller of a diverse portfolio of chemicals. Its offerings span basic, fine, and specialty chemicals, as well as performance pro...

Deepak Nitrite Limited Financial Statement Overview

Summary

Revenue growth is offset by severe margin compression and negative free cash flow. Gross margin fell from 41.3% to 14.7%, and FCF is deeply negative, indicating poor cash conversion. Balance sheet remains moderate, but declining ROE and rising debt add risk.

Income Statement

45Neutral

Balance Sheet

58Neutral

Cash Flow

32Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue96.31B77.85B80.91B76.10B78.83B67.73B
Gross Profit24.27B11.47B18.03B18.79B19.54B21.91B
EBITDA17.21B10.28B11.76B12.79B13.37B16.46B
Net Income10.62B5.51B6.97B8.11B8.52B10.67B
Balance Sheet
Total Assets98.14B86.81B77.18B60.96B51.29B44.30B
Cash, Cash Equivalents and Short-Term Investments3.72B4.64B9.14B5.83B4.16B4.79B
Total Debt17.62B16.38B12.67B2.86B728.60M3.15B
Total Liabilities32.92B28.11B22.93B12.74B10.39B10.92B
Stockholders Equity64.76B58.37B53.89B47.97B40.90B33.38B
Cash Flow
Free Cash Flow0-6.67B-4.83B1.06B2.89B6.37B
Operating Cash Flow05.17B6.39B8.78B6.50B8.24B
Investing Cash Flow0-6.85B-15.25B-7.22B-2.76B-4.24B
Financing Cash Flow02.32B8.26B435.30M-3.59B-3.86B

Deepak Nitrite Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1530.15

Price Trends

50DMA1565.04Negative
100DMA1628.38Negative
200DMA1616.19Negative

Market Momentum

MACD4.72Negative
RSI48.91Neutral
STOCH46.41Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DEEPAKNTR, the sentiment is Negative. The current price of 1530.15 is below the 20-day moving average (MA) of 1532.65, below the 50-day MA of 1565.04, and below the 200-day MA of 1616.19, indicating a neutral trend. The MACD of 4.72 indicates Negative momentum. The RSI at 48.91 is Neutral, neither overbought nor oversold. The STOCH value of 46.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DEEPAKNTR.

Deepak Nitrite Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:DEEPAKNTR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:GNFCIN:GNFC71OutperformINR 68.62B6.50―4.51%22.49%65.41%
IN:DEEPAKFERTIN:DEEPAKFERT65NeutralINR 183.08B15.58―0.69%13.94%18.32%
IN:VALIANTORGIN:VALIANTORG63NeutralINR 9.50B13.78――21.32%175.87%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:DEEPAKNTRIN:DEEPAKNTR52NeutralINR 211.97B19.66―0.49%25.13%99.89%
IN:ACIIN:ACI49NeutralINR 53.93B53.23―0.58%5.99%-41.58%
IN:TATACHEMIN:TATACHEM47NeutralINR 165.54B-6.89―1.72%4.93%-1174.55%

* General Sector Average

Performance Comparison

0%50%IN:DEEPAKNTRIN:ACIIN:DEEPAKFERTIN:GNFCIN:TATACHEMIN:VALIANTORGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:DEEPAKNTR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:DEEPAKNTRDeepak Nitrite Limited1530.15-87.71-5.42%
IN:ACIArchean Chemical Industries Ltd.432.45-102.43-19.15%
IN:DEEPAKFERTDeepak Fertilisers and Petrochemicals Corporation Ltd.1440.5087.536.47%
IN:GNFCGujarat Narmada Valley Fertilizers & Chemicals Ltd.465.40-5.11-1.09%
IN:TATACHEMTata Chemicals Limited639.15-153.03-19.32%
IN:VALIANTORGValiant Organics Limited321.8564.8025.21%

Deepak Nitrite Limited Corporate Events

Deepak Nitrite schedules Q2 and H1 FY27 earnings call for October 30

Oct 16, 2026

Deepak Nitrite Limited has announced that it will host an earnings conference call to discuss its financial results for the second quarter and half year of FY27, ended 30 September 2026. The call, scheduled for Friday, 30 October 2026 at 3:30 PM IST...

Deepak Nitrite Discloses Resignation of Life Sciences SBU Head

Aug 21, 2026

Deepak Nitrite Limited has announced a managerial change in its life sciences strategic business unit, with the resignation of Mr. Puneet Sharma as SBU Head – Life Sciences. His resignation is effective from the close of business on 21 August 2026, a...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026